Feb 10 (Reuters) - Vanda Pharmaceuticals Inc :
* VANDA PHARMACEUTICALS REPORTS FOURTH QUARTER AND FULL YEAR 2020 FINANCIAL RESULTS
* VANDA PHARMACEUTICALS INC - Q4 2020 TOTAL REVENUES GREW TO $67.7 MILLION, AN 11% INCREASE COMPARED TO Q4 2019
* VANDA PHARMACEUTICALS INC - END OF YEAR 2021 CASH EXPECTED TO BE GREATER THAN $400 MILLION
* VANDA PHARMACEUTICALS INC SEES 2021 TOTAL REVENUES $270 TO $300 MILLION
* VANDA PHARMACEUTICALS INC QTRLY EARNINGS PER SHARE $0.15
Source text for Eikon: Further company coverage:
((Reuters.Briefs@thomsonreuters.com;)
* VANDA PHARMACEUTICALS REPORTS FOURTH QUARTER AND FULL YEAR 2020 FINANCIAL RESULTS
* VANDA PHARMACEUTICALS INC - Q4 2020 TOTAL REVENUES GREW TO $67.7 MILLION, AN 11% INCREASE COMPARED TO Q4 2019
* VANDA PHARMACEUTICALS INC - END OF YEAR 2021 CASH EXPECTED TO BE GREATER THAN $400 MILLION
* VANDA PHARMACEUTICALS INC SEES 2021 TOTAL REVENUES $270 TO $300 MILLION
* VANDA PHARMACEUTICALS INC QTRLY EARNINGS PER SHARE $0.15
Source text for Eikon: Further company coverage:
((Reuters.Briefs@thomsonreuters.com;)